Skip to main content
Fig. 3 | Insights into Imaging

Fig. 3

From: Magnetic resonance imaging for treatment response evaluation and prognostication of hepatocellular carcinoma after thermal ablation

Fig. 3

Gadobenate dimeglumine–enhanced axial MRI scans in a 57-year-old man with hepatitis B virus (A-H). A 1.7-cm steatotic mass is detected in segments VII. The mass shows T1 hypointensity (A), signal intensity reduced on out-of-phase TIWI (arrow in B), moderate T2 hyperintensity (C), marked hyperintensity on DWI (b = 1000 s/mm2) (D), rim enhancement on arterial phase image (E), “wash-out” appearance on portal venous phase (F) and equilibrium phase (G), marked hepatobiliary phase hypointensity (H). The recurrence-free survival for this patient was 150 days

Back to article page